Latest Form 4 insider transactions

David Tsao, Chief Technology Officer and a Director of BillionToOne, Inc., sold 3,333 shares of common stock on September 24, 2026 for $125.00 per share.

Bosch John Roderick Ten, SVP of Laboratory Operations of BillionToOne, Inc., sold 1,416 shares of common stock on September 24, 2026 for $120.00 per share.

Todd M. Scheub, Executive Vice President of Finward Bancorp, purchased 32 shares of common stock on September 25, 2026 for $43.48 per share.

Andrew Bliss, a Director of Bullish, sold 100 shares of common stock on September 24, 2026 for $40.10 per share.

Bruce L. Claflin, a Director of Ciena Corp, sold 2,857 shares of common stock on September 24, 2026 for $355.91 per share.

William E Brown, Chairman, a Director and 10% owner of Central Garden & Pet Co, reported a transaction in 1,000 shares of common stock on September 24, 2026.

Gifford Fong, a Director of Primeenergy Resources Corp, reported a transaction in 15,000 shares of common stock on September 24, 2026.

Mark Lappe, Chief Executive Officer and a Director of Inhibrx Biosciences, Inc., purchased 10,000 shares of common stock on September 25, 2026.

Jerry Hao Ting, a Director of Asana, Inc., received 38,802 shares of common stock on September 25, 2026.

David Robert Bogart, Chief Commercial Officer and a Director of Conexeu Sciences Inc., reported multiple transactions in common stock on September 25, 2026.

Thomas Berquist, a Director of Asana, Inc., received 38,802 shares of common stock on September 25, 2026.

John M Sullivan, a Director of Vici Properties Inc., received 5,562 shares of common stock on September 24, 2026.

William Franklin Mudd, See Remarks of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Peter Herweck, a Director of Teradyne, Inc, reported multiple transactions in common stock on September 24, 2026.

Emmis Capital Sponsor LLC reported changes in beneficial ownership of Emmis Acquisition Corp. common stock on September 25, 2026.

Thomas L Seavey, a Director of Hennessy Advisors Inc, sold 1,875 shares of common stock on September 24, 2026 for $10.15 per share.

D Jonathan Merriman, a Director of PodcastOne, Inc., purchased 11,000 shares of common stock on September 24, 2026 for $2.21 per share.

Michael Fierman, a Director and 10% owner of Angel Oak Mortgage REIT, Inc., purchased 38,726 shares of common stock on September 25, 2026 for $7.50 per share.

Robert Weir, See Remarks of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

City National Rochdale Strategic Credit Fund, an interval fund focused on debt securities and credit-related investments, has filed an amendment to its registration statement, detailing its investment strategies, risks, and operational updates.

John Ackerman, a Director of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Ugur Sahin, Chief Executive Officer and 10% owner of BioNTech SE, sold 61,000 shares of common stock on September 25, 2026.

Thomas J Salentine Jr, a Director and 10% owner of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Kimberly S Lubel, a Director of Arcosa, Inc., reported a transaction in 683 shares of common stock on September 25, 2026.

Louis Edward Tamayo, Chief Financial Officer of Lexeo Therapeutics, Inc., received 54,750 shares of common stock on September 24, 2026.

Narinder Pal Bhalla, Chief Medical Officer of Lexeo Therapeutics, Inc., reported multiple transactions in common stock on September 24, 2026.

Jose Manuel Otero, Chief Operating Officer of Lexeo Therapeutics, Inc., reported multiple transactions in common stock on September 24, 2026.

Richard Nolan Townsend, Chief Executive Officer and a Director of Lexeo Therapeutics, Inc., reported multiple transactions in common stock on September 24, 2026.

David Norman Martin, See Remarks of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Anthony Puntillo, a Director of Finward Bancorp, purchased 5 shares of common stock on September 25, 2026 for $43.46 per share.